Continental Building Products, Inc. (NYSE:CBPX), a leading manufacturer of gypsum wallboard and complementary finishing products, announced results for the first quarter ended March 31, 2014. Net sales for the first quarter of 2014 totaled $87.0 million, up 4.2%, compared to $83.5 million in the first quarter of 2013. Continental Building Products Inc (NYSE:CBPX), net profit margin is 5.30% and weekly performance is -1.74%. On last trading day company shares ended up $16.41. Analysts mean target price for the company is $22.13. Continental Building Products Inc (NYSE:CBPX), distance from 50-day simple moving average (SMA50) is -10.36%.
Cara Therapeutics Inc (NASDAQ:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors, announced financial results for the first quarter ended March 31, 2014. Net Loss Available to Common Stockholders: The Company reported net loss available to common stockholders of $3.4 million, or $0.22 per basic and diluted share, for the first quarter of 2014, compared to net loss available to common stockholders of $1.7 million, or $0.48 per basic and diluted share, for the same period last year. Cara Therapeutics Inc (NASDAQ:CARA), fell 1.73% in last trading session and ended the day on $13.64. CARA, return on assets is -22.50%. Cara Therapeutics Inc (NASDAQ:CARA), quarterly performance is -0.29%.
2U Inc (NASDAQ:TWOU), a leading provider of cloud-based software-as-a-service solutions for leading nonprofit colleges and universities to deliver their high-quality degree programs online, reported financial and operating results for the three months ended March 31, 2014. Revenue was $26.3 million, an increase of 38% percent from the $19.1 million in the first quarter of 2013.Net loss attributable to common stockholders, on a GAAP basis, was $(7.1) million, or $(0.93) per share, compared to$(3.8) million, or $(0.52) per share, in the first quarter of 2013. Pro forma net loss per share was $(0.20).Adjusted EBITDA loss was $(3.8) million, compared to $(2.4) million in the first quarter of 2013. 2U Inc (NASDAQ:TWOU), shares moved down 1.46% in last trading session and was closed at $10.77, while trading in range of $ 10.60 – 11.21. 2U Inc (NASDAQ:TWOU), year to date (YTD) performance is -22.96%.
Lumenis Ltd (NASDAQ:LMNS), the world’s largest medical laser company for surgical, ophthalmic and aesthetic applications, announced first quarter 2014 financial results. Total revenue in the first quarter of 2014 was $65.8 million, an increase of 9.5% compared to revenue of $60.1 million last year. Product revenue was $52.6 million, an increase of 11.5% compared to product revenue of $47.2 million last year. First quarter 2014 gross profit was $34.6 million, an increase of $3.9 million, or 12.7%, compared to $30.7 million last year. First quarter 2014 gross margin was 52.6%, compared to 51.1% last year, an increase of 151 basis points. Lumenis Ltd (NASDAQ:LMNS), ended the last trading day at $9.52. Company weekly volatility is calculated as 6.56% and price to cash ratio as 8.01. Lumenis Ltd (NASDAQ:LMNS), showed a positive weekly performance of 8.68%.
Everyday Health Inc (NYSE:EVDY), a leading digital health and wellness company, announced financial results for the first quarter ended March 31, 2014. First quarter total revenue grew 23% year-over-year to $37.5 million. Advertising and sponsorship revenue grew 29% year-over-year to $32.7 million.Average revenue per advertiser increased 43% year-over-year.Adjusted EBITDA was $3.2 million in the first quarter of 2014 compared to $166 thousand in the same quarter last year. Everyday Health Inc (NYSE:EVDY), net profit margin is -11.60% and weekly performance is -14.72%. On last trading day company shares ended up $12.05. Analysts mean target price for the company is $19.00. Everyday Health Inc (NYSE:EVDY), distance from 50-day simple moving average (SMA50) is -13.67%.